基础医学与临床 ›› 2013, Vol. 33 ›› Issue (9): 1165-1170.

• 研究论文 • 上一篇    下一篇

CD45RO N-糖基化位点对galectin-3结合CD45RO突变体转染细胞的影响

薛婧,高锡强,傅春燕,魏强   

  1. 中国医学科学院医学实验动物研究所
  • 收稿日期:2013-04-22 修回日期:2013-06-22 出版日期:2013-09-05 发布日期:2013-08-28
  • 通讯作者: 魏强 E-mail:virolab@cnilas.org
  • 基金资助:
    协和青年基金;中央高校基本科研业务费专项资金

Effect of CD45RO N-glycosylation sites on galectin-3 binding to CD45RO mutant-transfected cells

  • Received:2013-04-22 Revised:2013-06-22 Online:2013-09-05 Published:2013-08-28

摘要: 目的 构建CD45RO不同N-糖基化位点突变的T细胞株,并检测其与galectin-3的结合情况。方法 采用N→Q定点突变技术分别去除CD45RO的11个N-糖基化位点,制备单个N-糖基化位点缺失的CD45RO,然后将其导入慢病毒表达载体pWPXL中,11个携带单个N-糖基化位点缺失的CD45RO重组慢病毒质粒与慢病毒包装质粒psPAX2和MD2.G共转染293T细胞,将包装重组慢病毒感染CD45ˉ的J45.01细胞,流式分选后获得11株分别表达CD45RO单个N-糖基化位点缺失的J45.01 T细胞株。通过RT-PCR和流式细胞术分别从RNA水平和蛋白水平验证CD45RO突变体的转录和表达,应用流式细胞术检测CD45RO突变细胞株与galectin-3的结合情况。结果 成功构建了11个CD45RO单个N-糖基化位点缺失的T细胞株,各突变细胞株能稳定表达突变基因,经测序再次证实突变位点正确,CD45RO突变体能稳定表达于细胞表面。galectin-3与N327Q突变细胞的结合明显增强,与N36Q突变细胞和N217Q突变细胞的结合明显减弱。结论 CD45RO N-糖基化位点对galectin-3与CD45RO-J45.01细胞的结合有调节作用。

关键词: 半乳糖凝集素-3, 结合, N-糖基化位点, CD45RO, Jurkat T细胞

Abstract: Objective To construct eleven cell lines each of which expressed CD45RO with removal of one N-glycosylation site and to examine its binding to galectin-3. Methods Individual site-directed N→Q mutagenesis of N-glycosylation site was performed for all eleven N-glycosylation sites in CD45RO and cloned into lentiviral vector pWPXL. Recombinant lentiviral was produced by 293T cells with co-transfection of pWPXL-mutated-CD45RO, the packaging plasmids psPAX2 and MD2.G. Human J45.01 cells were infected by the recombinant lentiviruses. The expression of CD45RO mutants was confirmed by RT-PCR and flow cytometry, and the binding of these cell lines to galectin-3 was evaluated by flow cytometry. Results Eleven cell lines each of which expressed CD45RO with removal of one N-glycosylation site were successfully constructed. RT-PCR, DNA sequencing and flow cytometry analysis revealed that the mutations were correct and CD45RO with removal of one N-glycosylation site was stably expressed on the surface of each cell lines. It was observed that galectin-3-binding to N327Q mutant was largely enhanced, to N36Q or N217Q mutant was largely suppressed. Conclusion Galectin-3 binding to CD45RO-J45.01 cells is regulated by N-glycosylation sites in CD45RO.

Key words: Galectin-3, binding, N-glycosylation site, CD45RO, Jurkat T cell

中图分类号: